Stevanato Group S.p.A.
STVN
Rang in aandelen
#3364
Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and... Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.
Aandeelprijs
$19.00
Marktkapitalisatie
$5.19B
Verandering (1 dag)
-0.13%
Verandering (1 jaar)
-26.55%
Land
IT
Handel Stevanato Group S.p.A. (STVN)
Categorie
Healthcare
Winst voor Stevanato Group S.p.A. (STVN)
Winst in Jun 2026 TTM: $227.33M
Volgens de meest recente financiële verslagen van Stevanato Group S.p.A. bedraagt de huidige winst van het bedrijf $227.33M. In 2023 behaalde het bedrijf een winst van $209.54M, een stijging ten opzichte van de winst van 2022, die $201.28M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Stevanato Group S.p.A. van 2019 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $227.33M | 36.29% |
| 2024 | $166.79M | -20.40% |
| 2023 | $209.54M | 4.11% |
| 2022 | $201.28M | 6.84% |
| 2021 | $188.39M | 60.67% |
| 2020 | $117.26M | 91.01% |
| 2019 | $61.39M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $3.81B | 1,574.16% |
US
|
|
| $4.11B | 1,707.47% |
FR
|
|
| - | - |
JP
|
|
| $1.59B | 599.44% |
US
|
|
| - | - |
CH
|
